Rosiglitazone does not improve cognition or global function when used as adjunctive therapy to AChE inhibitors in mild-to-moderate Alzheimer's disease: two phase 3 studies (Q84140005)
Jump to navigation
Jump to search
scientific article published on 01 August 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rosiglitazone does not improve cognition or global function when used as adjunctive therapy to AChE inhibitors in mild-to-moderate Alzheimer's disease: two phase 3 studies |
scientific article published on 01 August 2011 |
Statements
Rosiglitazone does not improve cognition or global function when used as adjunctive therapy to AChE inhibitors in mild-to-moderate Alzheimer's disease: two phase 3 studies (English)
C Harrington
S Sawchak
C Chiang
J Davies
C Donovan
A M Saunders
M Irizarry
B Jeter
M Zvartau-Hind
C H van Dyck
1 August 2011